# Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial).

> **NCT04788186** · PHASE4 · UNKNOWN · sponsor: **University of Saskatchewan** · enrollment: 200 (estimated)

## Conditions studied

- Coronary Artery Disease
- Acute Myocardial Infarction
- Coronary Artery Stenosis
- ST Elevation Myocardial Infarction
- Non-ST Elevation Myocardial Infarction (NSTEMI)

## Interventions

- **DRUG:** De-prescribe beta blocker therapy

## Key facts

- **NCT ID:** NCT04788186
- **Lead sponsor:** University of Saskatchewan
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-23
- **Primary completion:** 2024-08-31
- **Final completion:** 2025-08-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2022-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04788186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04788186, "Beta Blocker De-prescription Following Coronary Artery Bypass Graft Surgery (BEEFBURGER Trial).". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04788186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*